Soleus Capital Management »

Teva Pharmaceutical Industries shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $58M 5.6M 10.44
2023-09-30 $62M 6.1M 10.20
2023-06-30 $32M 4.3M 7.53

More positions owned by Soleus Capital Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Rayzebio
Edap Tms S A Sponsored Adr (EDAP)
Organogenesis Hldgs (ORGO)
Humana (HUM)
Celcuity (CELC)
Iradimed (IRMD)
Essa Pharma Com New (EPIX)
SurModics (SRDX)
Hca Holdings (HCA)
Vaxcyte (PCVX)
Neuropace (NPCE)
Nuvalent Inc-a (NUVL)

View all positions for Soleus Capital Management

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Harel Insurance Investments & Financial Services
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Meitav Dash Investments

View all funds holding Teva Pharmaceutical Industries